An interview with Texas Retina Associates’ Rajiv Anand, MD, is featured by the American Academy of Ophthalmology (AAO) in their latest video from the recent 2018 American Society of Retina Specialists (ASRS) annual meeting. Dr. Anand discusses interim results from a randomized clinical trial of ranibizumab, with or without targeted panretinal photocoagulation (tPRP), in patients who develop radiation retinopathy after treatment for uveal melanoma. Watch the video here.